Answer
Rapid intravenous infusion of desferrioxamine mesilate (Desferal) may cause hypotension and shock, including flushing, tachycardia, circulatory collapse and urticaria; intravenous treatment should therefore only be given as slow infusions.
Sources for this answer
- Desferal Vials, 500mgNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 14Document updated
Sources checked